Cargando…
FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma
BACKGROUND/AIM: The prognosis of hepatocellular carcinoma (HCC) is very dismal and the targeted drugs of HCC are limited. Studies of HCC prognostic biomarkers have made little progress, though many new techniques such as high-throughput sequencing have been applied. FOS-like antigen 1 (FOSL1) is gen...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941458/ https://www.ncbi.nlm.nih.gov/pubmed/31274473 http://dx.doi.org/10.4103/sjg.SJG_595_18 |